Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -543 | -8,314 | 231 | -128 | -4,280 |
| Depreciation Amortization | 199 | 575 | 385 | 214 | 190 |
| Accounts receivable | -676 | N/A | -1,276 | -920 | N/A |
| Accounts payable and accrued liabilities | 379 | N/A | 356 | 311 | N/A |
| Other Working Capital | -330 | -1,748 | -1,073 | -735 | -320 |
| Other Operating Activity | 1,846 | 8,518 | 943 | 622 | 20 |
| Operating Cash Flow | $875 | $-969 | $-434 | $-636 | $-4,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -177 | -2,030 | -1,805 | -599 | -730 |
| Other Investing Activity | 0 | -175 | -125 | -89 | -50 |
| Investing Cash Flow | $-177 | $-2,205 | $-1,930 | $-688 | $-780 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 3,500 | 1,500 | N/A |
| Other Financing Activity | 0 | 3,500 | 0 | 0 | 4,000 |
| Financing Cash Flow | $N/A | $3,500 | $3,500 | $1,500 | $4,000 |
| Beginning Cash Position | 498 | 172 | 172 | 172 | 1,340 |
| End Cash Position | 1,196 | 498 | 1,308 | 348 | 170 |
| Net Cash Flow | $698 | $326 | $1,136 | $176 | $-1,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | 875 | -969 | -434 | -636 | -4,390 |
| Capital Expenditure | -177 | N/A | -1,875 | -669 | N/A |
| Free Cash Flow | 698 | -969 | -2,309 | -1,305 | -4,390 |